期刊文献+

雌激素不同给药方法对去卵巢大鼠子宫内膜安全性的实验研究 被引量:5

Experimental study on the adult castrated rat endometrium by different estrogen dosage methods
原文传递
导出
摘要 目的 研究雌激素不同给药方法对去卵巢大鼠子宫内膜的安全性。 方法 选用雌性大鼠 5 0只 ,随机分为 5组 :对照组、去卵巢组、已烯雌酚每天服药组、每 3d服药组及加黄体酮组。第13周对各组大鼠子宫内膜进行组织学观察及形态计量测定。 结果 去卵巢组子宫内膜萎缩、变薄 ,腺体稀少而直 ;每天组宫腔扩大 ,腺上皮细胞明显增大水肿 ;每 3d组及加黄体酮组均呈早期增生期改变。子宫内膜腺上皮细胞高度每天组 (16 2 3± 2 34) μm、每 3d组 (11 85± 0 78) μm、加黄体酮组 (12 4 0± 0 2 1) μm ,均高于去卵巢组 (7 74± 1 11) μm ,各组之间比较差异有显著性 (P <0 0 5 )。 结论 去卵巢组大鼠子宫内膜腺上皮细胞高度对雌激素较敏感 ,雌激素可改善子宫内膜萎缩状态 ,每 3d给药和加黄体酮联合给药对子宫内膜增生影响较小。 Objective To study the safety of adult castrated rat endometrium by different estrogen dosage methods. Methods Fifty SD female rats were randomly divided into sham castration group, castration group, daily diethylstilbestrol group, every three day diethylstilbestrol group and diethylstilbestrol plus progesterone group. The pathological changes of endometrium were observed and variance of endometrium was measured in morphometry at the 13th week after operation. Results The endometrium of castration group was thin and atrophied and the gland decreased in number and became straight in shape. The uterus cavity of daily diethylstilbestrol group was enlarged with gland epithelial cells dilated and edematous. The early proliferative endometrium was observed in both every three day diethylstilbestrol group and diethylstilbestrol plus progesterone group. The height of endometrium gland epithelial cells was (16.23±2.34) μm in everyday group, (11.85±0.78) μm in every three day diethylstilbestrol group and (12.40±0.21) μm in diethylstilbestrol plus progesterone group respectively, showing significant difference compared with that of the castration group (7.74±1.11) μm,P<0.05). Conclusions The height of gland epithelial cells in endometrium of castrated female rats is a sensitive index for evaluating the effect of estrogen. Estrogen alters the atrophy status of castrated rat endometriun. Every three day diethylstilbestrol and diethylstilbestrol plus progesterone affect less on endometrium proliferation.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2003年第6期353-355,共3页 Chinese Journal of Geriatrics
关键词 绝经 雌激素替代疗法 子宫内膜 黄体酮 Estrogen replacement therapy Endometrium
  • 相关文献

参考文献7

  • 1谭建三,李洪洋,刘宏伟,杨式之.雌激素对去势宫内膜影响的形态计量评价[J].华西医科大学学报,1993,24(2):179-181. 被引量:4
  • 2魏杨,薛加强,林守清,徐小梅,许仙玲.绝经后应用激素替代治疗妇女的子宫内膜细胞形态观察[J].中华妇产科杂志,1997,32(7):432-435. 被引量:29
  • 3阮云军,吴赛珠,孟素荣,周可祥,翁心植,朱小虎,彭健,郭志刚.激素替代治疗对去卵巢大鼠动脉的雌激素受体表达的影响[J].中华老年医学杂志,2000,19(5):358-360. 被引量:9
  • 4Graser T, Koytchev R, Muller A, et al. Comparison of the efficacy and endometrial safety of two estradiot valerate/dienogest combinations and kliogest for continuous combined hormone replacement therapy in postmenopausal women.Climacteric ,2000,3 : 109-118.
  • 5Andrade PM, Baracat EC, Simoes MJ, et al.Histomorphometric aspects of adult castrated rat endometrium after the use of estrogen, progesterone and tamoxifen. Clin Exp Obstet Gynecol, 2000,27 : 138-141.
  • 6Lindgren R, Mattsson LA, Andersson K, et al. Transvaginal ultrasonography and endometrial histology in peri-and postmenopausal women on hormone replacement therapy. Br J Obstet Gynaecol, 1999,106 : 421-426.
  • 7Gibbons WE, Thorneycroft IH. Protecting the endometrium.Opposing the hyperplasia/malignancy potential of ERT. J Reprod Med , 1999,44 : 203-208.

二级参考文献8

共引文献39

同被引文献57

  • 1杨维益,梁嵘,杨敏,贾旭,李峰,文平,杨淑珍.健脾理气法对骨骼肌能量代谢影响的研究[J].中国运动医学杂志,1994,13(1):28-31. 被引量:85
  • 2Guadalupe-Grau A, Fuentes T, Guerra B, et al. Exercise and bone mass in adults. Sports Med, 2009,39(6) :439-468.
  • 3Suominen H. Muscle training for bone strength. Aging Clin Exp Res, 2006,18(2) :85-93.
  • 4Papapetropoulos A, Rudic RD, Sessa WC. Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovasc Res, 1999, 15,43(3):509-520.
  • 5Jung JY, Pashia ME, Nishimoto SY, et al. A possible role for nitric oxide in osteoclastogenesis associated with cholesteatoma. Otol Neurotol, 2004,25 (5) :661-668.
  • 6Davies SA, Dow JA. Modulation of epithelial innate immunity by autocrine production of nitric oxide. Gen Comp Endocrinol, 2009,15,162(1) :113-121.
  • 7Pennisi P, D'Alcamo MA, Leonetti C, et al. Supplementation of L-arginine prevents glucoeortieoid-induced reduction of bone growth and bone turnover abnormalities in a growing rat model. J Bone Miner Metab, 2005,23(2) :134-139.
  • 8Samuels A, Perry MJ, Gibson RL, et al. Role of endothelial nitric oxide synthase in estrogen-induced osteogenesis. Bone, 2001,29 ( 1 ) :24-29.
  • 9Wei CL, Hon WM, Lee KH, et al. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats. Liver Int, 2005, 25 ( 3 ) :647-656.
  • 10Islas-Carbajal MC, Covarrubias A, Grijalva G, et al. Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats. Liver lnt,2005,25 ( 1 ) : 131-140.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部